Tralokinumab-ldrm is approved for the treatment of moderate-to-severe AD in adult and adolescent patients 12 years and older in the European Union, Canada, Great Britain, the United Arab Emirates, ...

Next is superficial pyoderma, which clinicians see most often. Signs include folliculocentric pustules and spreading crusts; hair often becomes trapped in the crust and falls out. Clients often do not ...

Christina Gentry, DVM, DACVM, shared a key dermatology takeaway from her co-presented CE session on concurrent disease.

Although it looked to be lights out for InflaRx’s C5a antibody vilobelimab in the rare skin disorder pyoderma gangrenosum (PG) last year, the German drugmaker ended 2025 with a glimmer of hope for the ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...

“Marta Petersen, MD has specialized expertise in complex medical dermatology. She is board certified in both Internal Medicine and Dermatology and is participating in Maintenance of Certification in ...

SPOKANE, Wash. — A Spokane father is facing a devastating choice between financial ruin and his life as he battles an extremely rare disease that requires tens of thousands in monthly medication to ...

Pyoderma gangrenosum lesion regression after dapsone treatment. However, after two weeks, the patient’s hematological condition deteriorated, presenting with a hemoglobin level of 7 g/dL, white blood ...

(A) Oval and elongated yeast-like structures in the deep dermis. (PAS, ×400). (B) Patient’s cat with nasal ulceration diagnosed as sporotrichosis. Only 10 published cases of PGLS were found in the ...